Huntington's disease-like 2: a clinical, pathological, and molecular comparison to Huntington's disease

被引:8
|
作者
Margolis, RL
Holmes, SE
机构
[1] Dept Psychiat, Div Neurobiol, Lab Genet Neurobiol, Baltimore, MD 21287 USA
[2] Johns Hopkins Univ, Sch Med, Program Cellular & Mol Med, Baltimore, MD 21287 USA
关键词
Huntington's disease; trinuleotide repeat expansion; inclusion; neurodegeneration; striatum; caudate; basal ganglia; Junctophilin;
D O I
10.1016/S1566-2772(03)00061-6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Huntington's disease-like 2 (HDL2) is a recently described disorder caused by a CTG/CAG expansion mutation on chromosome 16q24.3. Like Huntington's disease (HD), it is an adult onset, progressive, neurodegenerative autosomal dominant disorder clinically characterized by abnormal movements, dementia, and psychiatric syndromes. Almost all known affected individuals are of African ancestry. Pathologically, it is very similar to HD, with prominent cortical and striatal atrophy and intranuclear inclusions. Most surprisingly, however, the available evidence suggests that it is not a polyglutamine disease. Rather, the repeat expansion is located within junctophilin-3 in the CTG orientation. Here we review the clinical, pathological, and molecular features of HDL2 in comparison with HD, and speculate about how the distinct mutations of these disorders lead to such similar clinical and pathological phenotypes. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:187 / 196
页数:10
相关论文
共 50 条
  • [1] The Neuropsychiatry of Huntington Disease-Like 2: A Comparison with Huntington's Disease
    Ferreira-Correia, Aline
    Krause, Amanda
    Anderson, David G.
    [J]. JOURNAL OF HUNTINGTONS DISEASE, 2020, 9 (04) : 325 - 334
  • [2] Huntington's disease-like 2
    Margolis, R. L.
    Rudnicki, D. D.
    [J]. NEUROACANTHOCYTOSIS SYNDROMES II, 2008, : 59 - +
  • [3] Huntington's disease-like 2: Clinical features
    Walker, RH
    Margolis, RL
    [J]. MOVEMENT DISORDERS, 2005, 20 (12) : 1675 - 1676
  • [4] Huntington's disease and Huntington's disease-like syndromes: an overview
    Goevert, Felix
    Schneider, Susanne A.
    [J]. CURRENT OPINION IN NEUROLOGY, 2013, 26 (04) : 420 - 427
  • [5] Comparison of the Huntington's Disease like 2 and Huntington's Disease Clinical Phenotypes
    Anderson, David G.
    Ferreira-Correia, Aline
    Rodrigues, Filipe B.
    Aziz, N. Ahmad
    Carr, Jonathan
    Wild, Edward J.
    Margolis, Russell L.
    Krause, Amanda
    [J]. MOVEMENT DISORDERS CLINICAL PRACTICE, 2019, 6 (04): : 302 - 311
  • [6] A comparison of Huntington disease and Huntington disease-like 2 neuropathology
    Rudnicki, Dobrila D.
    Pletnikova, Olga
    Vonsattel, Jean-Paul G.
    Ross, Christopher A.
    Margolis, Russell L.
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2008, 67 (04): : 366 - 374
  • [7] Genetic heterogeneity of Huntington's Disease: screening of Huntington's disease-like 1 and 2 loci
    Stevanin, G
    Lebre, AS
    Jeannequin, C
    Julien, C
    Camuzat, A
    Sahloul, R
    San, C
    Margolis, RL
    Dode, C
    Durr, A
    Brice, A
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 : 269 - 269
  • [8] Pathogenic insights from Huntington's disease-like 2 and other Huntington's disease genocopies
    Margolis, Russell L.
    Rudnicki, Dobrila D.
    [J]. CURRENT OPINION IN NEUROLOGY, 2016, 29 (06) : 743 - 748
  • [9] Emerging differences between Huntington's disease-like 2 and Huntington's disease: A comparison using MRI brain volumetry
    Anderson, David G.
    Haagensen, Mark
    Ferreira-Correia, Aline
    Pierson, Ronald
    Carr, Jonathan
    Krause, Amanda
    Margolis, Russell L.
    [J]. NEUROIMAGE-CLINICAL, 2019, 21
  • [10] The Neuropsychiatric Manifestations of Huntington's Disease-Like 2
    Fischer, Christopher A.
    Licht, Eliot A.
    Mendez, Mario F.
    [J]. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2012, 24 (04) : 489 - 492